iX Biopharma Ltd. (SG:42C) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
iX Biopharma Ltd. has enhanced its Scientific Advisory Board by appointing Dr. Brian Kennedy, a renowned expert in aging and longevity, as a scientific advisor. Dr. Kennedy’s expertise will be pivotal for iX Biopharma’s development and commercialization of innovative healthspan products, including their NAD+ sublingual wafers. This strategic move is expected to advance the company’s research efforts and boost their market presence in the health and wellness sector.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.
